Equillium, Inc.
EQ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746466
No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Equillium, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 30 | 25 | −5 |
| Shares | 12.7M | 12.6M | −99.1K (−0.8%) |
| Value | $39.7M | $25.6M | −$14.1M (−35.6%) |
New holders (1)
Institutions that held Equillium, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 16,500 | $34.0K | 0.00% |
Sold out (6)
Institutions that held Equillium, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Jane Street Group, LLC | 15,018 | $47.0K |
| Dimensional Fund Advisors LP | 13,109 | $41.0K |
| Two Sigma Securities, LLC | 12,388 | $39.0K |
| FMR LLC | 10,264 | $32.0K |
| BNP Paribas Arbitrage, SA | 555 | $1.75K |
| AdvisorNet Financial, Inc | 19 | $0 |